[1] Uchino K, Tateishi R, Shiina S, et al. Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors. Cancer, 2011,117:4475-4483.
[2] Lin CY, Chen JH, Liang JA, et al. 18F-FDG PET or PET/CT for detecting extrahepaticmetastatis or recurrent hepatocellular carcinoma: A systematic review and metaanalysis. Eur J Radiol,2012,81:2417-2422.
[3] Lee JH, Park JY, Kim DY, et al. Prognostic value of 18F-FDG PET for hepatocellular carcinoma patients treated with sorafenib. Liver Int, 2011,31:1144-1149.
[4] Cholongitas E, Mamou C, Rodríguez-Castro KI, et al. Mammalian target of rapamycin inhibitors are associated with lower rates of hepatocellular carcinoma recurrence after liver transplantation: a systematic review. Transpl Int,2014,27:1039-1049. |
